Coexistence of NDM-1-producing Escherichia Coli and Citrobacter Freundii in the Same Patient.

Bo Zhu,Chaoqun Ying,Hao Xu,Jingjing Ying
DOI: https://doi.org/10.1016/j.jgar.2018.04.013
IF: 4.349
2018-01-01
Journal of Global Antimicrobial Resistance
Abstract:Objectives: Although bla(NDM-1) has been widely detected in various Enterobacteriaceae clinical isolates, multiple bla(NDM-1) colonisations within the same patient remain rare. The aim of the study was to describe a patient with respiratory tract colonisation with NDM-1-producing Escherichia coli and Citrobacter freundii during hospitalisation in China. Methods: Two carbapenem-resistant isolates were analysed. Antimicrobial susceptibility testing, metallo-beta-lactamase production, conjugation assay, plasmid analysis and molecular typing were performed. Results: The two clinical isolates carried the blaNDM-1 gene and showed resistance to carbapenems. S1 nuclease pulsed-field gel electrophoresis (S1-PFGE) revealed that E. coli NB753 harboured a plasmid of ca. 80 kb, and C. freundii NB865 harboured three plasmids (ca. 70, 80 and 135 kb). Southern blot and Inc replicon typing further demonstrated that both isolates carried the blaNDM-1 gene on a self-transferrable IncX3 plasmid. Moreover, the two NDM-producing plasmids were conjugative and the transconjugants showed increased resistance to carbapenems. Conclusion: An NDM-1-encoding plasmid harboured by various clinical isolates in a single patient is worrying considering that this plasmid may be widespread in our hospital. Furthermore, the threat of carbapenemase-producing bacterial epidemics should be closely monitored. However, a limitation of this study was the extremely small sample size. (C) 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?